Table 1.

Characteristics of the subjects

Patients	Age years	Gender	Duration years	Peanut allergy symptoms	Severity
1	8	female	7	wheezing, throat swelling	severe
2	3	male	2	asthma, throat swelling, loss of voice	severe
3	5	female	4	abdominal pain, systemic urticaria, throat itching	moderate
4	9	female	8	urticaria, angioedema, wheezing	severe
5	4	female	5	wheezing	mild
6	7	female	7	angioedema	severe
7	9	male	9	wheezing, angioedema	severe
8	18	female	19	wheezing, angioedema	severe
9	6	male	5	wheezing, angioedema	severe
10	21	male	20	wheezing, angioedema	severe
11*	5	female	4	urticaria, angioedema, wheezing	severe
12*	24	male	23	urticaria, angioedema, abdominal pain, vomiting, diarrhea, difficulty wheezing	severe
13*	8	male	7	wheezing, hypotension	severe
14*	7	male	6	lip swelling, throat swelling	severe
15*	6	male	5	throat swelling	severe
16	28	female	27	oral food challenge	moderate

^*These subjects were part of a phase I open-label study of omalizumab.